Bristol Myers Squibb Co Drug Patent Portfolio

Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Status

Bristol Myers Squibb Co's Family Patents

Given below is the complete list of Bristol Myers Squibb Co's drugs and the patents protecting them.

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Bristol Myers Squibb's schizophrenia medication does not succeed in crucial trial when used alongside antipsychotic treatments.

23 Apr, 2025

Reasons Bristol Myers Squibb (BMY) is Considered a Strong Long-Term Value Investment - Yahoo Finance

22 Apr, 2025

Regulatory Agency in the United States Greenlights Bristol Myers Squibb's Schizophrenia Medication

27 Sep, 2024

FDA is set to review the approval of the first new drug for schizophrenia in more than three decades

26 Sep, 2024